MedScout Secures $15M Series A Investment to Accelerate Growth

AUSTIN, TX — MedScout, a revenue acceleration platform revolutionizing commercial operations for medtech and life sciences companies, has closed a $15M Series A funding round led by Fulcrum Equity Partners, with continued support from existing investors, Stage 2 and LiveOak Ventures. This funding will accelerate MedScout's strong progress in providing advanced sales intelligence tools purpose-built for selling into healthcare.

"After three and a half years partnering with hundreds of medtech companies, we’re thrilled to have reached this milestone," said Skylar Talley, Co-Founder and CEO of MedScout. "From day one, our vision has been clear: to develop a platform indispensable to every medical device rep in the field. With this new capital, we can now turn that vision into a reality."

“We are excited to partner with Skylar and the MedScout team and continue to be impressed with what they have built,” said Philip Lewis of Fulcrum Equity Partners. “The company has very quickly become a key technology that powers the growth of medical device companies, and we are excited by the meaningful opportunity MedScout has to drive growth not only by adding product depth but also by scaling the platform to new areas of healthcare.” 

Mandy Cole, Partner at Stage 2 Capital shared “The growth Medscout has seen since our investment is a testament to how they are helping medtech and life sciences companies improve sales efficiency and growth. We are excited to continue to partner with their team as they keep delighting their customers with best in class sales intelligence technology. “

"MedScout’s platform is transforming the sales process for leading medtech companies,” said Mike Marcantonio, Partner at LiveOak Ventures. “We’re thrilled to continue supporting the company in its next stage of growth as it provides sales teams and leaders across the healthcare industry with the tools they need to get innovative medical technology into physicians’ hands faster and ultimately drive better patient outcomes.”

‍

About MedScout

MedScout is a revenue acceleration platform designed to transform sales processes for medtech and life sciences companies. By combining advanced medical claims intelligence with an intuitive user experience and integrations with leading CRMs, MedScout empowers sales professionals and leaders to optimize their sales territories, prioritize best-fit opportunities, sell more efficiently, and build stronger relationships with physicians. 

‍

About Fulcrum Equity Partners‍

Fulcrum Equity Partners is an Atlanta-based growth equity firm that gives entrepreneurs the capital and hands-on support they need to take their companies further, faster. Fulcrum invests in healthcare services and B2B tech executives searching for $5 million to $35 million of equity in minority and majority growth opportunities. Fulcrum’s partners believe in building businesses the right way, meeting teams where they are, and helping them imagine a bigger and brighter future by building the right systems, processes, teams, and culture. All of that starts with the right experience, the right support, and the right relationship. Learn more at http://www.fulcrumep.com.

‍

About Stage 2 Capital

The first go-to-market venture capital firm, Stage 2 Capital combines traditional venture investing and go-to-market execution expertise, leveraging its elite LP base of 500+ senior executives from unicorns and Fortune 500 firms to help portfolio companies scale revenue and accelerate growth. Co-founded in 2018 by Jay Po, former investor at Bessemer Venture Partners, and Mark Roberge, founding CRO at HubSpot, Stage 2 Capital invests in B2B software and marketplaces between late seed stage and Series A. For more information, visit: http://www.stage2.capital.

‍

About LiveOak Ventures

LiveOak Ventures is an early-stage venture capital firm based in Austin, Texas. With 25 years of successful venture investing in Texas, the founders of LiveOak have helped create nearly $5 billion of enterprise value. LiveOak is a complete life cycle investor focused on technology and technology-enabled service companies. With nearly $500M under management and led/co-led over 60 high-growth investments in Texas-based leaders, such as AmplifAI, DISCO (NYSE: LAW), Eventus, Homeward, Osano, SchooLinks, Take Command Health, and many more. The firm was honored at the inaugural Austin A-List Awards in 2022 as the Venture Capital Firm of the Year and received the Austin Gives Charitable Champion award. For more information, visit: https://liveoak.vc/.